26
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Cardiac Tamponade as Initial Presentation of Systemic Lupus Erythematosus in Third-Trimester Pregnancy

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Patient: Female, 21-year-old

          Final Diagnosis: Cardiac tamponade • lupus nephritis • preeclampsia • systemic lupus erythematosus

          Symptoms: Chest pain • depression • rash • sore throat

          Medication: —

          Clinical Procedure: —

          Specialty: Rheumatology

          Objective:

          Rare coexistence of disease or pathology

          Background:

          Systemic lupus erythematosus (SLE) is a common autoimmune disorder in women of childbearing age. It can present during pregnancy and can lead to poor maternal and fetal outcomes, with a higher risk of preterm birth and pre-eclampsia. Women are at a higher risk of lupus flares during pregnancy, especially if undiagnosed or if disease is poorly controlled. Cardiac tamponade is a rare complication of SLE and can be fatal.

          Case Report:

          A 21-year-old primigravida African American woman with a history of asthma presented with progressive pleuritic left shoulder pain. She had a recent history of sore throat, facial rash, and depressed mood after sun exposure. A work-up was strongly positive for antinuclear antigen, anti-Smith, anti-Smith/ribonucleoprotein, anti-chromatin, anti-SSA, anti-SSB, anti-dsDNA, and low C3. Echocardiogram showed hemodynamically stable cardiac tamponade. The patient also had proteinuria and hypertension attributed to pre-eclampsia. However, a renal biopsy confirmed lupus nephritis. The patient was treated with pericardiocentesis, prednisone, azathioprine, and hydroxychloroquine. There was significant clinical improvement with resolution of cardiac tamponade and improvement in renal function.

          Conclusions:

          Cardiac tamponade is a rare and life-threatening manifestation of SLE. Prompt work-up and treatment with immunosuppressants and pericardiocentesis is needed to improve maternal and fetal outcomes. SLE patients are at higher risk of exacerbations of the disease during pregnancy. It is also important to rule out lupus nephritis in an SLE patient with pre-eclampsia. This report shows the importance of accurate diagnosis of SLE in pregnancy and the appropriate management to ensure the best outcomes for the mother and fetus.

          Related collections

          Most cited references15

          • Record: found
          • Abstract: found
          • Article: not found
          Is Open Access

          Update οn the diagnosis and management of systemic lupus erythematosus

          Clinical heterogeneity, unpredictable course and flares are characteristics of systemic lupus erythematosus (SLE). Although SLE is—by and large—a systemic disease, occasionally it can be organ-dominant, posing diagnostic challenges. To date, diagnosis of SLE remains clinical with a few cases being negative for serologic tests. Diagnostic criteria are not available and classification criteria are often used for diagnosis, yet with significant caveats. Newer sets of criteria (European League Against Rheumatism (EULAR)/American College of Rheumatology (ACR) 2019) enable earlier and more accurate classification of SLE. Several disease endotypes have been recognised over the years. There is increased recognition of milder cases at presentation, but almost half of them progress overtime to more severe disease. Approximately 70% of patients follow a relapsing-remitting course, the remaining divided equally between a prolonged remission and a persistently active disease. Treatment goals include long-term patient survival, prevention of flares and organ damage, and optimisation of health-related quality of life. For organ-threatening or life-threatening SLE, treatment usually includes an initial period of high-intensity immunosuppressive therapy to control disease activity, followed by a longer period of less intensive therapy to consolidate response and prevent relapses. Management of disease-related and treatment-related comorbidities, especially infections and atherosclerosis, is of paramount importance. New disease-modifying conventional and biologic agents—used alone, in combination or sequentially—have improved rates of achieving both short-term and long-term treatment goals, including minimisation of glucocorticoid use.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Cardiac manifestations of systemic lupus erythematosus.

            The heart is one of the most frequently affected organs in SLE. Any part of the heart can be affected, including the pericardium, myocardium, coronary arteries, valves, and the conduction system. In addition to pericarditis and myocarditis, a high incidence of CAD has become increasingly recognized as a cause of mortality, especially in older adult patients and those with long-standing SLE. Many unanswered questions remain in terms of understanding the pathogenesis of cardiac manifestations of SLE. It is not currently possible to predict the patients who are at greatest risk for the various types of cardiac involvement. However, with the rapid advancement of basic science and translational research approaches, it is now becoming easier to identify specific mutations associated with SLE. A better understanding of these genetic factors may eventually allow clinicians to categorize and predict the patients who are at risk for specific cardiac manifestations of SLE.
              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              Update on the epidemiology, risk factors, and disease outcomes of systemic lupus erythematosus

                Bookmark

                Author and article information

                Journal
                Am J Case Rep
                Am J Case Rep
                amjcaserep
                The American Journal of Case Reports
                International Scientific Literature, Inc.
                1941-5923
                2022
                10 July 2022
                : 23
                : e936273-1-e936273-6
                Affiliations
                [1 ]Department of Medicine, Division of Rheumatology, Case Western Reserve University School of Medicine and University Hospitals Cleveland Medical Center, Cleveland, OH, USA
                [2 ]Department of Medicine and Pediatrics, Case Western Reserve/University Hospitals Cleveland Medical Center and Rainbow Babies and Children’s Hospital, Cleveland, OH, USA
                Author notes
                Corresponding Author: Patrick A. Yousif, e-mail: patrickyousif@ 123456hotmail.com

                Authors’ Contribution:

                [A]

                Study Design

                [B]

                Data Collection

                [C]

                Statistical Analysis

                [D]

                Data Interpretation

                [E]

                Manuscript Preparation

                [F]

                Literature Search

                [G]

                Funds Collection

                Financial support: Funding of this manuscript was provided by the Division of Rheumatology at Case Western Reserve/University Hospitals Cleveland Medical Center

                Conflict of interest: None declared

                Article
                936273
                10.12659/AJCR.936273
                9280115
                35810325
                59d8e718-2a20-4991-a232-b4888b0a3992
                © Am J Case Rep, 2022

                This work is licensed under Creative Common Attribution-NonCommercial-NoDerivatives 4.0 International ( CC BY-NC-ND 4.0)

                History
                : 30 January 2022
                : 03 May 2022
                : 25 May 2022
                Categories
                Articles

                cardiac tamponade,lupus erythematosus, systemic,lupus nephritis,pre-eclampsia,pregnancy trimester, third

                Comments

                Comment on this article